NCT06734689View on ClinicalTrials.gov

Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

January 20, 2028

Study Completion Date

July 20, 2028

Conditions
ICI-myocarditis
Trial Locations (1)

75013

Hôpital Pitié Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06734689 - Genetic Determinants of Myocarditis Induced by Immune-checkpoint Inhibitors | Biotech Hunter | Biotech Hunter